基于聚(L-谷氨酸)树状分子的智能药物释放系统研究

以天然氨基酸L-谷氨酸为原料,通过收敛法合成了聚(L-谷氨酸)树状分子,通过半胱氨酸将抗肿瘤药物甲氨蝶呤( MTX)键合到聚(L-谷氨酸)树状分子上,构建氧化还原敏感的药物传输系统.用核磁(1H～NMR)等对载体以及载药粒子进行了表征.体外释放研究发现,载药粒子具有良好的氧化还原响应性,在不同浓度的还原剂二硫苏糖醇(D...     

基于聚氨基酸的线型-树状聚两性电解质的合成及pH响应性研究

采用开环聚合、发散法以及"点击化学法"合成了线型-树状聚两性电解质.首先通过γ-苄基-L-谷氨酸酯羧酸酐(BLG-NCA)的开环聚合及发散合成法分别合成了叠氮端基聚(γ-苄基-L-谷氨酸酯)(PBLG-N3)及以炔基为内核的带有4个伯氨端基的第2.0代聚酰胺-胺(PAMAM-D2),再将二者通过"点击反应"制备的线型-树状嵌段共聚物PBLG-b-D2作为大分子引发剂,利用其末端氨基引发ε-苄氧羰基-L-赖氨酸羧酸酐(ZLL-NCA)的开环聚合,获得线型-树状嵌段共聚物PBLG-b-D2-(PZLL)4,再经酸解脱除PBLG上的苄基及PZLL上的苄氧羰基,获得目标产物聚(L-谷氨酸)-b-聚[酰胺-胺-聚(L-赖氨酸)](PLGA50-b-D2-(PLL9)4)线型-树状聚两性电解质.通过核磁(1H-NMR)、傅里叶变换红外光谱(FTIR)和凝胶渗透色谱(GPC)表征了聚合物分子结构、分子量及其分布;通过电导滴定法、1H-NMR、zeta电位、激光光散射(LLS)、扫描电子显微镜(SEM)及圆二色谱(CD)等方法研究了PLGA50-b-D2-(PLL9)4对溶液pH值响应性.结果表明随溶液pH由酸性转变为碱性,PLGA50-b-D2-(PLL9)4显示出了多重胶束化行为,同时不对称的线型-树状分子拓扑结构影响了聚集体的形貌,在酸性pH值下形成以PLGA为核的球形胶束,而在碱性pH值下形成以PLL为核的棒状胶束,并分别伴随着PLGA及PLL链段构象从无规线团向螺旋构象的转变.     

新型树状结构手性联二萘酚衍生物的合成及催化性能研究

报道了树状结构的手性联二萘酚(BINOL)配体的合成及其在二乙基锌对醛的不对称加成反应中的应用.(R)-2,2′-二羟基-1,1′-联萘-3,3′-二羧酸与末端为氨基的Frechet聚芳醚型树状分子经缩合反应,以中等产率得到0～3代的树状分子配体,用¹HNMR,IR和MALDI-TOF质谱进行了结构表征.这些树状手性配体与Ti(OPrⁱ)₄在无水甲苯溶液中形成的配合物是二乙基锌对醛不对称加成反应的高效催化剂,树状分子载体的体积对催化剂的对映选择性没有明显的影响.以邻氯苯甲醛为底物时,反应的对映选择性随树状分子代数的增加而有所提高.     

接枝树形支化分子双亲性嵌段共聚肽的合成及性能研究

分别以叠氮丙胺和丙炔胺为引发剂,采用氨基酸环内酸酐开环聚合法(NCA-ROP),引发L-谷氨酸-γ-苄酯-N-羧基-环内酸酐和L-谷氨酸-γ-氯乙醇酯-N-羧基-环内酸酐聚合得到链端基为叠氮基的聚(L-谷氨酸-γ-苄酯)(PBLG)和链端基为炔基的聚(L-谷氨酸-γ-氯乙醇酯)(PCELG)均聚物.联合点击化学法(click chemistry)制备了一系列聚(L-谷氨酸-γ-苄酯)-b-聚(L-谷氨酸-γ-氯乙醇酯)(PBLG-b-PCELG),再通过对嵌段共聚物侧基氯进行化学修饰,将二代的甲基烷氧醚类亲水性树形枝化分子(G2)接枝到侧链上,形成一系列树形支化分子接枝聚肽双亲性嵌段共聚物,通过核磁(NMR)、红外光谱(IR)和凝胶渗透色谱(GPC)对其化学结构进行了表征,并采用紫外-可见光谱(UV-Vis)研究了聚合物结构及其溶液浓度对其温敏行为的影响规律.     

聚(L-丙氨酸)-聚羟乙基谷氨酰胺双嵌段两亲性共聚多肽的合成及其在水溶液中的自组装

利用光气法分别以L-谷氨酸和L-丙氨酸为原料,合成了γ-谷氨酸苄酯-NCA单体和L-丙氨酸-NCA单体,再以三乙胺为引发剂,合成了聚(L-丙氨酸)-聚(γ-谷氨酸苄酯)(PLA50-b-PBLG20)双嵌段共聚多肽,并用乙醇胺对其中的PBLG嵌段进行亲核取代,把疏水性的苄酯侧链变为亲水性的羟烷酰胺侧链,得到双亲性的聚(L-丙氨酸)-聚羟乙基谷氨酰胺(PLA-b-PHEGA)双嵌段共聚多肽.利用红外光谱和核磁共振谱对产物进行了表征,用TEM研究了双嵌段共聚多肽PLA50-b-PHEGA20在水溶液中的自组装.研究结果表明,双嵌段共聚多肽在水溶液中可自组装形成囊泡.     

树状分子BINAP膦配体的合成及其在不对称氢化中的应用: 结构与性能关系探究

设计并合成了系列具有不同代数以及不同结构的手性树状分子BINAP配体. 以Ru-催化的2-芳基丙烯酸的不对称氢化和Rh-催化的乙酰氨基肉桂酸的不对称氢化为模型反应, 结合圆二色谱分析方法, 系统研究了树状分子催化剂的结构与催化性能的关系. 在2-芳基丙烯酸的不对称氢化中, 发现双边取代的树状分子催化剂表现出明显高于小分子催化剂的催化活性, 反应速度随着树状分子代数的增加而加快, 当反应溶剂由甲苯/甲醇(1∶1, V/V)变为纯甲苯时, 这种树状分子加速效应更加明显; 而单边取代的树状分子催化剂, 由于催化活性中心远离树状分子载体, 因此其催化活性与小分子催化剂几乎相同. 此外, 圆二色(CD)谱研究表明, 双边取代的树状分子配体有不同于单边取代树状分子配体和小分子BINAP配体的Cotton效应, 说明树状分子的引入可能影响到位于其核心的手性配体的微环境. 这些结果显示树状分子载体在催化活性中心周围所构筑的微环境在促进催化剂活性中发挥了关键作用. 这种“微环境效应”还在脱氢氨基酸的不对称氢化中得到了进一步证明. 最后, 通过溶剂沉淀法, 实现了树状分子催化剂与产物的方便分离, 催化剂至少可以回收使用三次, 其催化活性和对映选择性没有任何降低.     

温度和pH值双敏感的生物相容性三嵌段共聚物聚(2-乙基-2- 唑啉)-b-聚(ε-己内酯) -b-聚(L-谷氨酸)的合成和表征

研究了由温敏的聚(2-乙基-2-噁唑啉)和pH值敏感的聚(L-谷氨酸)组成的三嵌段共聚物,聚(2-乙基-2-噁唑啉)-b-聚(ε-己内酯)-b-聚(L-谷氨酸)的合成方法,(1)以对甲苯磺酸甲酯为引发剂引发2-乙基-2-噁唑啉进行正离子开环聚合反应,得到了羟基封端的聚(2-乙基-2-噁唑啉)(PEOz-OH);(2)以PEOz-OH为引发剂,以辛酸亚锡为催化剂,在氯苯中合成了PEOz-b-聚(ε-己内酯)两嵌段共聚物(PEOz-b-PCL-OH);(3)将PEOz-b-PCL-OH末端的羟基转换为氨基,得到氨基封端的两嵌段共聚物(PEOz-b-PCL-NH2);(4)以PEOz-b-PCL-NH2为引发剂引发γ-苄基-L-谷氨酸-N-羧酸酐(BLG-NCA)开环聚合,得到了PEOz-b-PCL-b-聚(γ-苄基-L-谷氨酸)(PEOz-b-PCL-b-PBLG)三嵌段共聚物;(5)以HBr的醋酸溶液为脱保护剂脱去苄基保护基,得到PEOz-b-PCL-b-聚(L-谷氨酸)(PEOz-b-PCL-b-PLGlu)三嵌段共聚物.采用1H-NMR、GPC和FT-IR表征了各步聚合物的结构、分子量和分子量分布.     

温度和pH值双敏感的生物相容性三嵌段共聚物聚(2-乙基-2-噁唑啉)-b-聚(ε-己内酯)-b-聚(L-谷氨酸)的合成和表征

研究了由温敏的聚(2-乙基-2-噁唑啉)和pH值敏感的聚(L-谷氨酸)组成的三嵌段共聚物,聚(2-乙基-2-噁唑啉)-b-聚(ε-己内酯)-b-聚(L-谷氨酸)的合成方法,(1)以对甲苯磺酸甲酯为引发剂引发2-乙基-2-噁唑啉进行正离子开环聚合反应,得到了羟基封端的聚(2-乙基-2-噁唑啉)(PEOz-OH);(2)以PEOz-OH为引发剂,以辛酸亚锡为催化剂,在氯苯中合成了PEOz-b-聚(ε-己内酯)两嵌段共聚物(PEOz-b-PCL-OH);(3)将PEOz-b-PCL-OH末端的羟基转换为氨基,得到氨基封端的两嵌段共聚物(PEOz-b-PCL-NH2);(4)以PEOz-b-PCL-NH2为引发剂引发γ-苄基-L-谷氨酸-N-羧酸酐(BLG-NCA)开环聚合,得到了PEOz-b-PCL-b-聚(γ-苄基-L-谷氨酸)(PEOz-b-PCL-b-PBLG)三嵌段共聚物;(5)以HBr的醋酸溶液为脱保护剂脱去苄基保护基,得到PEOz-b-PCL-b-聚(L-谷氨酸)(PEOz-b-PCL-b-PLGlu)三嵌段共聚物.采用1H-NMR、GPC和FT-IR表征了各步聚合物的结构、分子量和分子量分布.     

聚丙烯酰胺/聚L-谷氨酸苄酯接枝共聚物的合成及其胶束制备

以聚丙烯酰胺(PAM)为大分子引发剂, 采用开环聚合方法, 在N,N-二甲基甲酰胺(DMF)中引发L-谷氨酸苄酯环内酸酐(BLG-NCA)聚合合成了两亲性聚丙烯酰胺/聚L-谷氨酸苄酯接枝共聚物(PAM-g-BLG), 采用IR, 1H NMR和GPC方法对共聚物结构进行了表征; 用芘作荧光探针, 研究了共聚物胶束的形成及其临界胶束浓度(cmc), 利用动态光散射(DLS)和透射电镜(TEM)研究了胶束的粒径分布和形态. 结果表明, PAM能够引发BLG-NCA开环聚合得到接枝共聚物, 在一定条件下接枝共聚物能够形成球形的稳定胶束, cmc值和胶束粒径随着共聚物中疏水性聚L-谷氨酸苄酯(PBLG)链段含量的增加而减小.     

多响应性聚肽共混胶束的药物控释性能

合成了聚(L-谷氨酸)-b-聚氧化丙烯-b-聚(L-谷氨酸)(PLGA-b-PPO-b-PLGA)三嵌段聚肽共聚物.通过透射电镜、激光光散射与核磁共振等方法研究了其与聚乙二醇-6-聚氧化丙烯(PEG-b-PPO)两嵌段共聚物共混体系的自组装行为,使用紫外分光光度计探讨了负载阿霉素的共混聚集体在不同环境下的释药行为.结果表明:该体系形成了以PPO为内核,PLGA和PEG为壳的共混胶束,该共混胶束的释药行为不仅具有pH和温度的响应性,并且对共混胶束的组分具有依赖性.     

pH响应性树枝状聚合物-金纳米粒子复合药物载体的制备

以表面接枝聚乙二醇链的聚酰胺胺树枝状聚合物(PEG-PAMAM)为纳米载体, 在其内部空腔包覆金纳米粒子, 在金纳米粒子表面连接硫辛酸改性的阿霉素(LA-DOX), 从而间接实现了抗癌药物在PEG-PAMAM内的高效负载. 同时, LA-DOX中的酰腙键提供pH响应性, 实现了药物的pH响应性释放. 紫外-可见(UV-Vis)光谱表明, 包覆金纳米粒子的PEG-PAMAM纳米载体对LA-DOX的负载能力显著增强. 体外细胞实验表明, 负载LA-DOX的树枝状聚合物-金纳米粒子复合药物载体具有较强的抗肿瘤能力.     

Hollow‐Core Magnetic Colloidal Nanocrystal Clusters with Ligand‐Exchanged Surface Modification as Delivery Vehicles for Targeted and Stimuli‐Responsive Drug Release

The fabrication of hierarchical magnetic nanomaterials with well‐defined structure, high magnetic response, excellent colloidal stability, and biocompatibility is highly sought after for drug‐delivery systems. Herein, a new kind of hollow‐core magnetic colloidal nanocrystal cluster (HMCNC) with porous shell and tunable hollow chamber is synthesized by a one‐pot solvothermal process. Its novelty lies in the “tunability” of the hollow chamber and of the pore structure within the shell through controlled feeding of sodium citrate and water, respectively. Furthermore, by using the ligand‐exchange method, folate‐modified poly(acrylic acid) was immobilized on the surface of HMCNCs to create folate‐targeted HMCNCs (folate‐HMCNCs), which endowed them with excellent colloidal stability, pH sensitivity, and, more importantly, folate receptor‐targeting ability. These assemblages exhibited excellent colloidal stability in plasma solution. Doxorubicin (DOX), as a model anticancer agent, was loaded within the hollow core of these folate‐HMCNCs (folate‐HMCNCs‐DOX), and drug‐release experiments proved that the folate‐HMCNCs‐DOX demonstrated pH‐dependent release behavior. The folate‐HMCNCs‐DOX assemblages also exhibited higher potent cytotoxicity to HeLa cells than free doxorubicin. Moreover, folate‐HMCNCs‐DOX showed rapid cell uptake apart from the enhanced cytotoxicity to HeLa cells. Experimental results confirmed that the synthesized folate‐HMCNCs are smart nanovehicles as a result of their improved folate receptor‐targeting abilities and also because of their combined pH‐ and magnetic‐stimuli response for applications in drug delivery.     

Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties

Novel water-soluble dendritic-linear-brush-like triblock copolymer polyamidoamine-b-poly(2-(dimethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) (PAMAM-b-PDMAEMA-b-PPEGMA)-grafted superparamagnetic iron oxide nanoparticles (SPIONs) were successfully prepared via a two-step copper-mediated atom transfer radical polymerization (ATRP) method. The macroinitiators were immobilized on the surface of Fe(3)O(4) nanoparticles via effective ligand exchange of oleic acid with the propargyl focal point PAMAM-typed dendron (generation 2.0, denoted as propargyl-D(2.0)) containing four carboxyl acid end groups, following a click reaction with 2'-azidoethyl-2-bromoisobutylate (AEBIB). PDMAEMA and PPEGMA were grown gradually from nanoparticle surfaces using the "grafting from" approach, which rendered the SPIONs soluble in water and reversed aggregation. To the best of our knowledge, this is the first report that describes the functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers. The modified nanoparticles were systematically studied via TEM, FT-IR, DLS, XRD, NMR, TGA, and magnetization measurements. DLS measurement confirmed that the obtained dendritic-linear-brush-like triblock copolymer-grafted SPIONs had a uniform hydrodynamic particle size of average diameter less than 30 nm. The dendritic-linear-brush-like triblock copolymer-grafted SPIONs possessed excellent biocompatibility by methyl tetrazolium (MTT) assays against NIH3T3 cells and hemolysis assays with rabbit erythrocytes. Furthermore, an anticancer drug, doxorubicin (Dox), was used as a model drug and loaded into the dendritic-linear-brush-like triblock copolymer-grafted SPIONs, and subsequently, the drug releases were performed in phosphoric acid buffer solution pH = 4.7, 7.4, or 11.0 at 37 °C. The results verify that the dendritic-linear-brush-like triblock copolymer-grafted SPIONs possess pH-responsive drug release behavior. The Dox dose of the loaded and free drug required for 50% cellular growth inhibition was 2.72 and 0.72 μm/mL, respectively, according to MTT assay against a Hella cell line in vitro. Therefore, on the basis of its biocompatibility and drug release effect, the modified SPION could provide a charming opportunity to design some excellent drug delivery systems for therapeutic applications.     

Preparation of thermoresponsive and pH-sensitivity polymer magnetic hydrogel nanospheres as anticancer drug carriers

In this work, a novel thermo and pH responsive magnetic hydrogel nanosphere poly(N-isopropylacrylamide-co-acrylic acid)/Fe(3)O(4) (poly(NIPAAm-co-AA)/Fe(3)O(4)) has been successfully prepared. The magnetic hydrogel nanospheres with thermo and pH-sensitivity were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier transform infrared-spectrometer (FT-IR), UV-vis absorption spectroscopy, and vibrating sample magnetometer (VSM). The magnetic hydrogel nanospheres exhibited uniform sphere structures and superparamagnetic property. Finally, the drug loading capacities and the releasing behavior of the magnetic hydrogel nanospheres were investigated with doxorubicin hydrochloride (DOX) as an anticancer drug model. The resulting magnetic hydrogel nanospheres exhibited high encapsulation efficiency (95%) to DOX under an appropriate condition. In vitro release experiments revealed that release was faster at pH 5.3 (37°C) than at pH 7.4 (25°C) or pH 7.4 (37°C). The DOX-loaded magnetic hydrogel nanospheres also showed enhanced anticancer effect compared with the free drug in vitro. These presented results suggested that the magnetic hydrogel nanospheres have a potential as tumor targeting drug carrier.     

线性麦芽糊精聚合物功能化Fe3O4纳米复合物药物载体的合成和应用

采用共沉淀法制备得到了线性麦芽糊精聚合物功能化的Fe₃O₄磁性纳米粒子(LM-SP-MNPs),通过傅里叶变换红外光谱、透射电子显微镜、热重分析等技术对其结构、形貌进行了表征。 其粒径大小为(12±2) nm。 选取抗癌药物盐酸阿霉素(DOX)作为模型药物,运用荧光光谱法研究了LM-SP-MNPs的载药性能和释放行为,探讨了pH值对LM-SP-MNPs药物释放性能的影响。 最适pH条件下,LM-SP-MNPs对盐酸阿霉素的最大吸附量约为357.1 mg/g,吸附等温线符合Freundlich等温吸附模型。 LM-SP-MNPs与盐酸阿霉素的复合物(DOX@LM-SP-MNPs),在37 ℃的条件下药物在酸性条件下的释放效率大于中性条件。 pH=5.3时,盐酸阿霉素在7 h内的累积释放率为26.9%。 此外,细胞毒性试验表明,LM-SP-MNPs具有良好的生物相容性,而DOX@LM-SP-MNPs和肝癌细胞共培养后可以明显杀死HepG2肝癌细胞。     

Synthesis of Fe_3O_4@SiO_2@polymer nanoparticles for controlled drug release

Novel multifunctional nanoparticles containing a magnetic Fe3O4@SiO2 sphere and a biocompatible block copolymer poly(ethylene glycol)-b-poly(aspartate)(PEG-b-PAsp) were prepared.The silica coated on the superparamagnetic core was able to achieve a magnetic dispersivity,as well as to protect Fe3O4 against oxidation and acid corrosion.The PAsp block was grafted to the surface of Fe3O4@SiO2 nanoparticles by amido bonds,and the PEG block formed the outermost shell.The anticancer agent doxorubicin(DOX) was loade...     

Bifunctional nanoparticles with fluorescence and magnetism via surface-initiated AGET ATRP mediated by an iron catalyst

Fluorescent/magnetic nanoparticles are of interest in many applications in biotechnology and nanomedicine for its living detection. In this study, a novel method of surface modification of nanoparticles was first used to modify a fluorescent monomer on the surfaces of magnetic nanoparticles directly. This was achieved via iron(III)-mediated atom-transfer radical polymerization with activators generated by electron transfer (AGET ATRP). Fluorescent monomer 9-(4-vinylbenzyl)-9H-carbazole (VBK) was synthesized and was grafted from magnetic nanoparticles (ferroferric oxide) via AGET ATRP using FeCl(3)·6H(2)O as the catalyst, tris(3,6-dioxaheptyl)amine (TDA-1) as the ligand, and ascorbic acid (AsAc) as the reducing agent. The initiator for ATRP was modified on magnetic nanoparticles with the reported method: ligand exchange with 3-aminopropyltriethoxysilane (APTES) and then esterification with 2-bromoisobutyryl bromide. After polymerization, a well-defined nanocomposite (Fe(3)O(4)@PVBK) was yielded with a magnetic core and a fluorescent shell (PVBK). Subsequently, well-dispersed bifunctional nanoparticles (Fe(3)O(4)@PVBK-b-P(PEGMA)) in water were obtained via consecutive AGET ATRP of hydrophilic monomer poly(ethylene glycol) methyl ether methacrylate (PEGMA). The chemical composition of the magnetic nanoparticles' surface at different surface modification stages was investigated with Fourier transform infrared (FT-IR) spectra. The magnetic and fluorescent properties were validated with a vibrating sample magnetometer (VSM) and a fluorophotometer. The Fe(3)O(4)@PVBK-b-P(PEGMA) nanoparticles showed an effective imaging ability in enhancing the negative contrast in magnetic resonance imaging (MRI).     

聚乙二醇-聚谷氨酸-聚丙氨酸三嵌段共聚物的合成及其胶束的pH-响应性药物控制释放

通过大分子引发剂ω-胺基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和酸性水解制备了一种具有pH-响应性的三嵌段共聚物聚乙二醇-聚谷氨酸-聚丙氨酸(mPEG-PLGA-PLAA).通过核磁共振、ζ-电势、动态光散射、电子显微镜等手段表征了此类三嵌段共聚物的自组装过程及所形成胶束的pH-响应性.使用圆二色谱和红外光谱,分析了胶束结构随环境pH值转变过程中聚氨基酸链段二级结构的变化.以阿霉素作为模型药物,研究了三嵌段共聚物的载药能力和在不同pH条件下的药物释放能力.在碱性条件下,PLGA链段去质子化,链段从疏水性变为亲水性,胶束中间层由于水合作用变得松散,药物释放速率增加;在酸性条件下,PLGA链段质子化,不带电荷,与阿霉素药物分子间的静电相互作用消失.同时,PLGA链段α-螺旋含量增加,形成由链内氢键维持的刚性棒状结构,将链段周围包埋的药物分子"挤出",加速了药物的释放.     

Fabrication and characterization of gold nanospheres‐cored pH‐sensitive thiol‐ended triblock copolymer: A smart drug delivery system for cancer therapy

Conventional chemotherapy suffers lack of multidrug resistance (MDR), lack of bioavailability, and selectivity. Nano‐sized drug delivery systems (DDS) are developing aimed to solve several limitations of conventional DDS. These systems have been offered for targeting tumor tissue owing to enhanced long circulation time, drug solubility, their retention effect, and improved permeability. As a result, the aim of this project was the design and development of DDS for biomedical applications. For this purpose, gold nanospheres (GNSs) covered by pH‐sensitive thiol‐ended triblock copolymer [poly(methacrylic acid) ‐b‐poly(acrylamide) ‐b‐poly(ε‐caprolactone)‐SH; PMAA‐b‐PAM‐b‐PCL‐SH] for delivery of anticancer drug doxorubicin (DOX). The chemical structures of triblock copolymer were investigated by proton nuclear magnetic resonance (¹H NMR) and Fourier transform infrared (FTIR) spectroscopies. ¹H NMR spectroscopy and gel permeation chromatography (GPC) were used for calculating the molecular weights of each part in the nanocarrier. The success of coating, GNSs with triblock copolymer was considered by means of dynamic light scattering (DLS), FTIR, ultraviolet‐visible (UV‐Vis), and transmission electron microscopy (TEM) measurement. The pH‐responsive drug release ability, (DOX)‐loading capacity, biocompatibility, and in vitro cytotoxicity effects of the nanocarriers were also studied. As a result, it is expected that the synthesized GNSs@polymer‐DOX considered as a potential application in nanomedicine demand like smart drug delivery, imaging, and chemo‐photothermal therapy.     

抗癌载药体系Fe_3O_4@ZIF-8@PA的合成及药物释放

采用溶剂热法合成磁性Fe_3O_4纳米粒子,并以此为基底设计制备了一种具有pH响应核壳结构的磁性纳米复合材料Fe_3O_4@ZIF-8@PA.该材料的比饱和磁化强度可达35.46 A·m2/g,具有良好的磁性.Fe_3O_4纳米粒子呈球型结构,分散性良好.与基底相比,复合微球的粒径尺寸明显增大,但依然符合载体材料的理想尺寸且分布均匀.此外,载体具有多孔结构,表面积较大,载药效率和载药量分别高达96.4%和144.6 mg/g.在pH为7.4和5.0的条件下对载药纳米粒子进行了药物释放研究.24 h内,粒子在2种pH下累计释放量分别为39.8%和78.6%.通过药物缓释验证了载体的pH响应性能.在实验中引入了对癌细胞具有杀伤作用的植酸,使合成的载体具有一定的抗癌作用.同时采用四甲基偶氮唑盐(MTT)法对人骨肉瘤细胞(MG-63)进行了体外分析实验,证实材料与抗癌药物阿霉素(DOX)之间存在着一定的协同抗癌效果.